Article in Marine drugs, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors.
Fei-Hua YaoFaculty of Pharmacy, Institute of Marine Drugs, Guangxi University of Chinese Medicine, Nanning 530200, China.
Jie YangFaculty of Pharmacy, Institute of Marine Drugs, Guangxi University of Chinese Medicine, Nanning 530200, China.
Xiao-Yan LiFaculty of Pharmacy, Institute of Marine Drugs, Guangxi University of Chinese Medicine, Nanning 530200, China.
Shu-Fen XuFaculty of Pharmacy, Institute of Marine Drugs, Guangxi University of Chinese Medicine, Nanning 530200, China.
Kai LiuFaculty of Pharmacy, Institute of Marine Drugs, Guangxi University of Chinese Medicine, Nanning 530200, China.
Zhen-Zhou TangFaculty of Pharmacy, Institute of Marine Drugs, Guangxi University of Chinese Medicine, Nanning 530200, China.ORCID 0000-0002-5519-7467
Wei-Hui LiState Key Laboratory for Conservation and Utilization of Subtropical Agro-Bioresources, College of Life Science and Technology, Guangxi University, Nanning 530004, China.ORCID 0000-0001-7037-7610
Yong-Hong LiuFaculty of Pharmacy, Institute of Marine Drugs, Guangxi University of Chinese Medicine, Nanning 530200, China.ORCID 0000-0001-8327-3108
Xiang-Xi YiFaculty of Pharmacy, Institute of Marine Drugs, Guangxi University of Chinese Medicine, Nanning 530200, China.
Cheng-Hai GaoFaculty of Pharmacy, Institute of Marine Drugs, Guangxi University of Chinese Medicine, Nanning 530200, China.ORCID 0000-0002-7524-8049
Funding
Guangxi Special Support Program for Maritime Economic Talent Cultivation 2025XHRC27Guangxi Youth Qihuang Scholar Training Project GXQH202412Natural Science Foundation of Guangxi 2025GXNSFBA069086Regional Innovation and Development set up by National Natural Science Foundation U24A20809the Research Launching Fund Project from GXUCM Introduced the Doctoral 2023BS057Wellcome Trust 202404
6 · The paper itself
Abstract
Three new cyclic tetrapeptides (nectriatidels A-C,
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.
New Cyclopeptides and Curvularins from Marine-Derived Fungal-Bacterial Symbiont · full record | Socratic